We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+32.14%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$543M
AUM Growth
+$107M
Cap. Flow
+$4.49M
Cap. Flow %
0.83%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
3
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.78M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$6.9M
3
PRTA icon
Prothena Corp
PRTA
+$3.45M
4
PBYI icon
Puma Biotechnology
PBYI
+$3.12M

Top Sells

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$16.8M
2
HRTX icon
Heron Therapeutics
HRTX
+$1.95M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$289M 53.31%
13,086,038
-961,212
-7% -$16.8M
HRTX icon
2
Heron Therapeutics
HRTX
$86.3M
$140M 25.87%
5,744,096
-74,445
-1% -$1.95M
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$348M
$52M 9.58%
2,965,485
– –
LJPC
4
DELISTED
La Jolla Pharmaceutical Company
LJPC
$31.8M 5.85%
4,938,893
+1,060,000
+27% +$6.9M
PBYI icon
5
Puma Biotechnology
PBYI
$406M
$13.6M 2.5%
349,400
+102,000
+41% +$3.12M
CELG
6
DELISTED
Celgene Corp
CELG
$10.6M 1.94%
+111,844
New +$9.78M
PRTA icon
7
Prothena Corp
PRTA
$458M
$3.93M 0.72%
323,823
+276,213
+580% +$3.45M
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$846K 0.16%
600,000
– –
EQ icon
9
Equillium
EQ
$157M
$379K 0.07%
47,343
– –

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Tang Capital Management held 9 positions worth $543M, up 25% from $436M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management's Q1 2019 filing shows 1 new, 3 increased and 2 reduced positions. Its largest new stake was Celgene Corp: 111,844 shares worth $10.6M. The largest sale was Odonate Therapeutics, Inc. Common Stock, an estimated $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management's largest Q1 2019 buy was Celgene Corp: 111,844 shares worth $10.6M.
  • Tang Capital Management added most to La Jolla Pharmaceutical Company in Q1 2019, an estimated $6.9M increase.
  • Tang Capital Management's biggest Q1 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $16.8M.
  • Tang Capital Management's ten largest holdings make up 100% of its $543M portfolio in Q1 2019.
  • Tang Capital Management opened 1 new position and closed 0 in Q1 2019.
  • Tang Capital Management's portfolio value rose 25% quarter-over-quarter to $543M.

Based on Tang Capital Management's 13F filing for Q1 2019, filed 15 May 2019.